NASDAQ:SIBN SI-BONE (SIBN) Stock Price, News & Analysis $12.15 -0.17 (-1.38%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About SI-BONE Stock (NASDAQ:SIBN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SI-BONE alerts:Sign Up Key Stats Today's Range$12.07▼$12.4350-Day Range$12.15▼$16.0552-Week Range$11.76▼$21.70Volume217,144 shsAverage Volume519,247 shsMarket Capitalization$509.57 millionP/E RatioN/ADividend YieldN/APrice Target$23.00Consensus RatingBuy Company OverviewSI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Read More… Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. SI-BONE Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks87th Percentile Overall ScoreSIBN MarketRank™: SI-BONE scored higher than 87% of companies evaluated by MarketBeat, and ranked 146th out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingSI-BONE has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageSI-BONE has only been the subject of 2 research reports in the past 90 days.Read more about SI-BONE's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for SI-BONE are expected to grow in the coming year, from ($0.78) to ($0.68) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of SI-BONE is -13.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SI-BONE is -13.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSI-BONE has a P/B Ratio of 3.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about SI-BONE's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.86% of the outstanding shares of SI-BONE have been sold short.Short Interest Ratio / Days to CoverSI-BONE has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in SI-BONE has recently decreased by 14.74%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSI-BONE does not currently pay a dividend.Dividend GrowthSI-BONE does not have a long track record of dividend growth. Sustainability and ESG3.3 / 5Environmental Score-1.44 Percentage of Shares Shorted3.86% of the outstanding shares of SI-BONE have been sold short.Short Interest Ratio / Days to CoverSI-BONE has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in SI-BONE has recently decreased by 14.74%, indicating that investor sentiment is improving significantly. News and Social Media2.7 / 5News Sentiment0.77 News SentimentSI-BONE has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for SI-BONE this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for SIBN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, SI-BONE insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $299,558.00 in company stock.Percentage Held by InsidersOnly 3.90% of the stock of SI-BONE is held by insiders.Percentage Held by Institutions98.11% of the stock of SI-BONE is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about SI-BONE's insider trading history. Receive SIBN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter. Email Address SIBN Stock News HeadlinesSI-BONE, Inc. (NASDAQ:SIBN) Director Jeffrey W. Dunn Sells 1,609 SharesNovember 21 at 8:52 AM | insidertrades.comSI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024November 20 at 4:20 PM | globenewswire.comTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…November 21, 2024 | Colonial Metals (Ad)The Analyst Verdict: SI-BONE In The Eyes Of 4 ExpertsNovember 20 at 8:43 AM | benzinga.comSI-BONE (NASDAQ:SIBN) versus Quipt Home Medical (NASDAQ:QIPT) Head to Head ContrastNovember 19 at 3:43 AM | americanbankingnews.comFY2024 EPS Estimates for SI-BONE Raised by Cantor FitzgeraldNovember 19 at 1:53 AM | americanbankingnews.comSanta Clara company's hip fracture tech gains momentumNovember 14, 2024 | bizjournals.comSI-Bone’s Resilience and Growth Potential Amid Challenges: Analyst Maintains Buy RatingNovember 14, 2024 | markets.businessinsider.comSee More Headlines SIBN Stock Analysis - Frequently Asked Questions How have SIBN shares performed this year? SI-BONE's stock was trading at $20.99 at the beginning of the year. Since then, SIBN stock has decreased by 42.1% and is now trading at $12.15. View the best growth stocks for 2024 here. How were SI-BONE's earnings last quarter? SI-BONE, Inc. (NASDAQ:SIBN) released its quarterly earnings data on Monday, August, 5th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.04. The company earned $39.97 million during the quarter, compared to analysts' expectations of $38.95 million. SI-BONE had a negative net margin of 23.82% and a negative trailing twelve-month return on equity of 22.51%. Does SI-BONE have any subsidiaries? The following companies are subsidiaries of SI-BONE: SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD. When did SI-BONE IPO? SI-BONE (SIBN) raised $84 million in an IPO on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers. Who are SI-BONE's major shareholders? Top institutional shareholders of SI-BONE include Champlain Investment Partners LLC (6.72%), Bellevue Group AG (3.46%), State Street Corp (2.58%) and Wellington Management Group LLP (2.45%). Insiders that own company stock include Laura Francis, Anthony J Recupero, Anshul Maheshwari, Michael A Pisetsky, John Gordon Freund, Timothy E Davis Jr and Mika Nishimura. View institutional ownership trends. How do I buy shares of SI-BONE? Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of SI-BONE own? Based on aggregate information from My MarketBeat watchlists, some other companies that SI-BONE investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings8/05/2024Today11/21/2024Fiscal Year End12/31/2024Next Earnings (Estimated)2/24/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:SIBN CUSIPN/A CIK1459839 Webwww.si-bone.com Phone(408) 207-0700FaxN/AEmployees350Year Founded2008Price Target and Rating Average Stock Price Target$23.00 High Stock Price Target$32.00 Low Stock Price Target$18.00 Potential Upside/Downside+89.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.92) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-43,340,000.00 Net Margins-23.82% Pretax Margin-23.82% Return on Equity-22.51% Return on Assets-16.53% Debt Debt-to-Equity Ratio0.22 Current Ratio8.25 Quick Ratio7.22 Sales & Book Value Annual Sales$138.89 million Price / Sales3.67 Cash FlowN/A Price / Cash FlowN/A Book Value$3.93 per share Price / Book3.09Miscellaneous Outstanding Shares41,940,000Free Float40,302,000Market Cap$509.57 million OptionableOptionable Beta1.22 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:SIBN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SI-BONE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SI-BONE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.